Chief
Scientific Officer
Dr. Mark Perkins |
 |
Dr. Mark Perkins trained in Internal Medicine
and Pediatrics at Vanderbilt in Nashville,
Tennessee, and was chief resident in Pediatrics.
He had a research fellowship in the laboratory
of Infectious Diseases at the National
Institutes of Health in Bethesda, Maryland,
where his research focused broadly on the
development of respiratory virus vaccines, and
specifically on identifying genotypic changes
responsible for adaptation to low-temperature
growth (influenza) and monoclonal escape (RSV).
After returning to Vanderbilt to complete a
clinical fellowship in Infectious Diseases, he went
to Duke University, first as a Senior Fellow in
Clinical Microbiology, and then as a faculty member
in the Division of Infectious Diseases and
International Health. He worked in Brazil for 5
years to develop and co-direct a collaborative Duke
facility for research in tropical diseases and to
establish a reference diagnostic laboratory. Dr.
Perkins is Board Certified in Internal Medicine,
Pediatrics, Infectious Diseases, Clinical
Microbiology, and Tropical Medicine.
In 1998 he joined the Global Tuberculosis
Programme of the World Health Organization and the
following year established a Diagnostics unit in the
Special Programme for Research and Training in
Infectious Diseases (TDR). His group focused on the
development and evaluation of new diagnostics for
tuberculosis, malaria, schistosomiasis, leishmania,
trypanosomiasis and sexually transmitted diseases.
Funding from the Gates Foundation in 2001 allowed
the creation of a full program on TB diagnostics
within TDR. Another BMGF grant in 2003 established
the Foundation for Innovative New Diagnostics to
accelerate this work.
Contact:
mark.perkins@finddiagnostics.org
|
